Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Plos One|June 4, 2014
A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in EuropeStefan Vegter, Keith TolleyHealth Economics Review|April 22, 2016
Measuring quality of life in opioid-induced constipation: mapping EQ-5D-3 L and PAC-QOLAnthony James Hatswell, Stefan VegterBritish Journal of Clinical Pharmacology|March 18, 2010
Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced coughStefan Vegter, Lolkje T W de Jong-van den BergValue in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in chronic kidney disease before and during dialysisStefan Vegter, Keith Tolley, Michael S Keith, et al.Expert Review of Vaccines|July 31, 2008
Cost-effectiveness of varicella vaccination programs: an update of the literatureMark H Rozenbaum, Albert Jan van Hoek, Stefan Vegter, et al.Clinical Therapeutics|October 27, 2010
Review of regulatory recommendations for orphan drug submissions in the Netherlands and Scotland: focus on the underlying pharmacoeconomic evaluationsStefan Vegter, Mark H Rozenbaum, Roelien Postema, et al.Journal of the American Society of Nephrology : JASN|December 3, 2011
Sodium intake, ACE inhibition, and progression to ESRDStefan Vegter, Annalisa Perna, Maarten J Postma, et al.Pharmacoeconomics|June 20, 2008
Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelinesStefan Vegter, Cornelis Boersma, Mark Rozenbaum, et al.Pharmacoeconomics|February 19, 2021
Methodological Challenges in the Economic Evaluation of a Gene Therapy for RPE65-Mediated Inherited Retinal Disease: The Value of VisionSimone A Huygens, Matthijs M Versteegh, Stefan Vegter, et al.Journal of Bone and Mineral Metabolism|April 12, 2013
Persistence with osteoporosis medication among newly-treated osteoporotic patientsJob F M van Boven, Pieter T de Boer, Maarten J Postma, et al.Pageof 3